Tomas Nausèda
Director/Board Member at Baltvesta UAB
Profile
Tomas Nausèda is currently the Director at Baltvesta UAB, Director at Sirijus UAB, Director at Georgian Properties LLC, and Director at Credit Plus.
Previously, he worked as the Director at Sanitas AB from 2009 to 2011 and as the Development Director at Dujasta, Uab in 2000.
He graduated from Concordia University.
Tomas Nausèda active positions
| Companies | Position | Start |
|---|---|---|
Baltvesta UAB
 Baltvesta UAB Investment ManagersFinance Baltvesta UAB (Baltvesta) is an independent venture capital firm headquartered in Vilnius, Lithuania. The firm was founded in 2005. | Director/Board Member | - |
| Sirijus UAB | Director/Board Member | 17/08/2010 |
| Georgian Properties LLC | Director/Board Member | 17/03/2011 |
| Credit Plus | Director/Board Member | - |
Former positions of Tomas Nausèda
| Companies | Position | End |
|---|---|---|
Sanitas AB
 Sanitas AB Pharmaceuticals: MajorHealth Technology Sanitas AB manufactures pharmaceutical products. The company's main activities include manufacture and sale of carious generic medicine, development of new products, and toll manufacturing. Its products are divided into two categories namely Over the Counter and Prescription Products. Its Over the Counter Products consist of acetylsalicylic acid, alkostop, aprotinine, ascorbic acid, and argentum sulfathiazole. The firm's Prescrition Products include acetaminophen, paracetamol, coffein, aciclovirum natrium, aminophylline, and argentum sulfathiazole. The company was founded in 1922 and is headquartered in Kuanas, Lithuania. | Director/Board Member | 18/08/2011 |
| Dujasta, Uab | Corporate Officer/Principal | 31/12/1999 |
Training of Tomas Nausèda
| Concordia University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sanitas AB
Sanitas AB Pharmaceuticals: MajorHealth Technology Sanitas AB manufactures pharmaceutical products. The company's main activities include manufacture and sale of carious generic medicine, development of new products, and toll manufacturing. Its products are divided into two categories namely Over the Counter and Prescription Products. Its Over the Counter Products consist of acetylsalicylic acid, alkostop, aprotinine, ascorbic acid, and argentum sulfathiazole. The firm's Prescrition Products include acetaminophen, paracetamol, coffein, aciclovirum natrium, aminophylline, and argentum sulfathiazole. The company was founded in 1922 and is headquartered in Kuanas, Lithuania. | Health Technology |
Baltvesta UAB
Baltvesta UAB Investment ManagersFinance Baltvesta UAB (Baltvesta) is an independent venture capital firm headquartered in Vilnius, Lithuania. The firm was founded in 2005. | Finance |
| Sirijus UAB | |
| Georgian Properties LLC | |
| Credit Plus | |
| Dujasta, Uab |
- Stock Market
- Insiders
- Tomas Nausèda
